Home  /  Resource Library  /  Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab

Serum immunoglobulin G as a discriminator of infection in follicular lymphoma patients undergoing chemotherapy with bendamustine in combination with rituximab

follicular, indolent, treatment, chemoimmunotherapy, bendamustine, infection, Serum immunoglobulin, risk, Serum IgG